Know More About Skin Cancer
Skin cancer is the easiest cancer to find, yet a confirmed diagnosis takes time, skills, and expert judgment, along with various diagnostic tests like dermoscopy and biopsy. With Spectra-Scope®, physicians can make instant, scar-free, and highly accurate diagnosis for all types of skin cancers. It is simple to use. The combination of biochemical information on skin tissue as determined through laser-induced plasma spectroscopy plus the proprietary AI-based diagnostic algorithm create an almost immediate diagnosis of unrivaled clinical accuracy in both sensitivity and specificity.
Speclipse, Inc., a medical device company founded by Stanford University graduates and a dermatologist, offers the world first cancer diagnostic solution based on Laser-Induced Plasma Spectroscopy (LIPS) and Artificial Intelligence (AI) Technology. Its core technology, Spectra-Scope®, embodies a new solution to the diagnosis of skin cancers without compromising efficacy and accuracy, therefore preventing unnecessary biopsy.